Showing 1 - 4 results of 4 for search 'A. I. Sapina' Skip to content
    • About the Library
    • Rules and Regulations
    • Library Services
    • Library Hours
  • Library News
    • Digital Repository
    • Google Scholar
    • ResearchGate
    • AJoGPL
    • KURJ
    • AJLS
    • MyLOFT
    • Lexis Plus UK
    • Britannica Academic
    • Research Support Tools
    • Quick Resource Links
  • Login
Advanced
  • Author
  • A. I. Sapina
Showing 1 - 4 results of 4 for search 'A. I. Sapina', query time: 0.01s Refine Results
  1. 1
    Observational study of inclisiran effectiveness in Moscow healthcare

    Observational study of inclisiran effectiveness in Moscow healthcare by A. I. Sapina, Yu. Yu. Varlamova, M. G. Papyrina, A. S. Bezymyannyy, E. Yu. Vasilyeva

    Published 2023-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Use of antiplatelet agents in patients after myocardial infarction followed up in Moscow outpatient clinics. Results of a non-interventional prospective study

    Use of antiplatelet agents in patients after myocardial infarction followed up in Moscow outpatient clinics. Results of a non-interventional prospective study by A. I. Sapina, A. Yu. Lebedeva, P. P. Savvinova, E. A. Zorina, E. S. Kolosova, E. Yu. Vasilyeva

    Published 2024-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Effectiveness of inclisiran lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Moscow healthcare

    Effectiveness of inclisiran lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Moscow healthcare by A. I. Sapina, Yu. Yu. Varlamova, M. G. Papyrina, A. S. Bezymyanny, E. L. Kordzaya, E. Yu. Vasilyeva

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Evaluation of lipoprotein(a) — a novel cardiovascular risk factor in patients with atherosclerotic cardiovascular diseases receiving PCSK9-targeted therapy in Russian real-world practice

    Evaluation of lipoprotein(a) — a novel cardiovascular risk factor in patients with atherosclerotic cardiovascular diseases receiving PCSK9-targeted therapy in Russian real-world pr... by A. I. Sapina, Yu. Yu. Varlamova, M. G. Papyrina, A. S. Bezymyannyy, E. L. Kordzaya, E. Yu. Vasilyeva

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs